MIFlowCyt-EV: a framework for standardized reporting of extracellular vesicle flow cytometry experiments.

Extracellular vesicles flow cytometry framework reporting standardization

Journal

Journal of extracellular vesicles
ISSN: 2001-3078
Titre abrégé: J Extracell Vesicles
Pays: United States
ID NLM: 101610479

Informations de publication

Date de publication:
2020
Historique:
received: 08 05 2019
revised: 16 12 2019
accepted: 17 12 2019
entrez: 5 3 2020
pubmed: 5 3 2020
medline: 5 3 2020
Statut: epublish

Résumé

Extracellular vesicles (EVs) are small, heterogeneous and difficult to measure. Flow cytometry (FC) is a key technology for the measurement of individual particles, but its application to the analysis of EVs and other submicron particles has presented many challenges and has produced a number of controversial results, in part due to limitations of instrument detection, lack of robust methods and ambiguities in how data should be interpreted. These complications are exacerbated by the field's lack of a robust reporting framework, and many EV-FC manuscripts include incomplete descriptions of methods and results, contain artefacts stemming from an insufficient instrument sensitivity and inappropriate experimental design and lack appropriate calibration and standardization. To address these issues, a working group (WG) of EV-FC researchers from ISEV, ISAC and ISTH, worked together as an EV-FC WG and developed a consensus framework for the minimum information that should be provided regarding EV-FC. This framework incorporates the existing Minimum Information for Studies of EVs (MISEV) guidelines and Minimum Information about a FC experiment (MIFlowCyt) standard in an EV-FC-specific reporting framework (MIFlowCyt-EV) that supports reporting of critical information related to sample staining, EV detection and measurement and experimental design in manuscripts that report EV-FC data. MIFlowCyt-EV provides a structure for sharing EV-FC results, but it does not prescribe specific protocols, as there will continue to be rapid evolution of instruments and methods for the foreseeable future. MIFlowCyt-EV accommodates this evolution, while providing information needed to evaluate and compare different approaches. Because MIFlowCyt-EV will ensure consistency in the manner of reporting of EV-FC studies, over time we expect that adoption of MIFlowCyt-EV as a standard for reporting EV- FC studies will improve the ability to quantitatively compare results from different laboratories and to support the development of new instruments and assays for improved measurement of EVs.

Identifiants

pubmed: 32128070
doi: 10.1080/20013078.2020.1713526
pii: 1713526
pmc: PMC7034442
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1713526

Subventions

Organisme : NCATS NIH HHS
ID : UH3 TR000931
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL126497
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA218500
Pays : United States
Organisme : NCATS NIH HHS
ID : UH3 TR000891
Pays : United States
Organisme : NCATS NIH HHS
ID : UG3 TR002881
Pays : United States
Organisme : NIBIB NIH HHS
ID : R01 EB003824
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA BC011502
Pays : United States
Organisme : NCATS NIH HHS
ID : UH3 TR000903
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA BC011503
Pays : United States

Informations de copyright

© 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group on behalf of The International Society for Extracellular Vesicles.

Références

Methods Mol Biol. 2018;1678:79-92
pubmed: 29071676
Nanomedicine. 2018 Apr;14(3):801-810
pubmed: 29307842
Thromb Haemost. 2017 Jun 28;117(7):1296-1316
pubmed: 28569921
Nat Methods. 2017 Feb 28;14(3):228-232
pubmed: 28245209
Cytometry A. 2016 Feb;89(2):135-47
pubmed: 25688721
Sci Rep. 2017 May 12;7(1):1878
pubmed: 28500324
Cytometry A. 2016 Feb;89(2):159-68
pubmed: 25808430
Cytometry A. 2019 Jun 28;:
pubmed: 31250561
Curr Protoc Cytom. 2015 Jul 01;73:13.14.1-13.14.16
pubmed: 26132176
ACS Nano. 2018 Jan 23;12(1):671-680
pubmed: 29300458
Nat Protoc. 2012 Jun 14;7(7):1311-26
pubmed: 22722367
Clin Chem. 2018 Apr;64(4):680-689
pubmed: 29453194
Cytometry A. 2016 Feb;89(2):196-206
pubmed: 26484737
Nanomedicine. 2012 Jul;8(5):712-20
pubmed: 22024193
Cytometry A. 2008 Oct;73(10):926-30
pubmed: 18752282
J Thromb Haemost. 2012 May;10(5):919-30
pubmed: 22394434
Circ Res. 2017 May 12;120(10):1632-1648
pubmed: 28495994
Curr Protoc Cytom. 2018 Oct;86(1):e43
pubmed: 30168659
Cytometry. 1998 Oct 1;33(2):197-205
pubmed: 9773880
Org Biomol Chem. 2015 Oct 14;13(38):9775-82
pubmed: 26264754
J Thromb Haemost. 2018 Jul;16(7):1423-1436
pubmed: 29781099
Cytometry A. 2015 Nov;87(11):1052-63
pubmed: 25847910
J Thromb Haemost. 2010 Dec;8(12):2596-607
pubmed: 20880256
Curr Protoc Cytom. 2017 Jan 5;79:1.3.1-1.3.27
pubmed: 28055116
J Thromb Haemost. 2011 Jun;9(6):1216-24
pubmed: 21481178
J Extracell Vesicles. 2015 May 14;4:27066
pubmed: 25979354
Cytometry A. 2016 Feb;89(2):184-95
pubmed: 25857288
J Extracell Vesicles. 2019 Jun 19;8(1):1597603
pubmed: 31258878
Sensors (Basel). 2018 Aug 01;18(8):
pubmed: 30071576
J Extracell Vesicles. 2018 Nov 23;7(1):1535750
pubmed: 30637094
Cytometry A. 2013 Mar;83(3):301-5
pubmed: 23335161
J Extracell Vesicles. 2013 May 27;2:
pubmed: 24009894
Cytometry A. 2012 Sep;81(9):727-31
pubmed: 22887982
J Thromb Haemost. 2013 Apr 2;:
pubmed: 23551930
J Extracell Vesicles. 2019 Mar 21;8(1):1587567
pubmed: 30949308
Anal Chem. 2018 Nov 6;90(21):12768-12775
pubmed: 30277744
ACS Nano. 2016 Apr 26;10(4):3886-99
pubmed: 26978483

Auteurs

Joshua A Welsh (JA)

Translational Nanobiology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Edwin Van Der Pol (E)

Biomedical Engineering and Physics, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Laboratory Experimental Clinical Chemistry, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Vesicle Observation Center, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Ger J A Arkesteijn (GJA)

Department of Biochemistry and Cell Biology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.

Michel Bremer (M)

Institute for Transfusion Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Alain Brisson (A)

UMR-5248-CBMN, CNRS-University of Bordeaux-IPB, Pessac, France.

Frank Coumans (F)

Biomedical Engineering and Physics, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Laboratory Experimental Clinical Chemistry, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Vesicle Observation Center, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Françoise Dignat-George (F)

Center of Cardiovascular Research and Nutrition (C2VN) UMR-INSERM INRA 1263, Aix-Marseille Université, INSERM, Marseille, France.
Hematology and Vascular Biology Department, CHU La Conception, Assistance Publique-Hôpitaux de Marseille, Marseille, France.

Erika Duggan (E)

Scintillon Institute, San Diego, CA, USA.

Ionita Ghiran (I)

Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Bernd Giebel (B)

Institute for Transfusion Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

André Görgens (A)

Institute for Transfusion Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Clinical Research Center, Department for Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
Evox Therapeutics Ltd, Oxford, UK.

An Hendrix (A)

Laboratory of Experimental Cancer Research, Department of Human Structure and Repair, Ghent University Hospital, Ghent, Belgium.

Romaric Lacroix (R)

Center of Cardiovascular Research and Nutrition (C2VN) UMR-INSERM INRA 1263, Aix-Marseille Université, INSERM, Marseille, France.
Hematology and Vascular Biology Department, CHU La Conception, Assistance Publique-Hôpitaux de Marseille, Marseille, France.

Joanne Lannigan (J)

Flow Cytometry Core, School of Medicine, University of Virginia, Charlottesville, VA, USA.

Sten F W M Libregts (SFWM)

Department of Biochemistry and Cell Biology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.
NIHR Cambridge BRC Cell Phenotyping Hub, Department of Medicine, University of Cambridge, Cambridge, UK.

Estefanía Lozano-Andrés (E)

Department of Biochemistry and Cell Biology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.

Aizea Morales-Kastresana (A)

Translational Nanobiology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Stephane Robert (S)

Evox Therapeutics Ltd, Oxford, UK.

Leonie De Rond (L)

Biomedical Engineering and Physics, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Laboratory Experimental Clinical Chemistry, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Vesicle Observation Center, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Tobias Tertel (T)

Institute for Transfusion Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

John Tigges (J)

Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Flow Cytometry Core, Beth Israel Deaconess Medical Center, Boston, MA, USA.

Olivier De Wever (O)

Laboratory of Experimental Cancer Research, Department of Human Structure and Repair, Ghent University Hospital, Ghent, Belgium.

Xiaomei Yan (X)

MOE Key Laboratory of Spectrochemical Analysis & Instrumentation, Key Laboratory for Chemical Biology of Fujian Province, Department of Chemical Biology, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen, People's Republic of China.

Rienk Nieuwland (R)

Laboratory Experimental Clinical Chemistry, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Vesicle Observation Center, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Marca H M Wauben (MHM)

Department of Biochemistry and Cell Biology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.

John P Nolan (JP)

Scintillon Institute, San Diego, CA, USA.

Jennifer C Jones (JC)

Translational Nanobiology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Classifications MeSH